Describe the evidence supporting muscarinic acetylcholine receptor activation as a therapeutic approach in schizophrenia Evaluate the most up-to-date clinical trial data associated with both approved and investigational muscarinic acetylcholine receptor activators for schizophrenia Summarize the practical considerations for integrating muscarinic receptor activators into schizophrenia management, including treatment selection and sequencing and patient care optimization
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership · $99–598/yr
| New Membership – Standard | $349/yr |
| New Membership – Standard (2-year) | $598/yr |
| New Membership – Military/VA | $259/yr |
| New Membership – Student/Resident | $149/yr |
| Renewal Membership – Standard | $249/yr |
| Renewal Membership – Standard (2-year) | $478/yr |
+27 more tiers
Collected from the provider’s public pages · source
Specialties served/covered
- Child & Adolescent Psychiatry
- Clinical Informatics
- Communication & Shared Decision-Making
- General & Adult Psychiatry
- General Surgery
- Interventional Radiology
- Mood & Anxiety Disorders
- Neurology
- Neuroradiology
- Nuclear Medicine
- Pain Medicine
- Pediatric Neurology
- Practice Management & Ethics
- Psychopharmacology
- Psychotic Disorders
- Sleep Medicine
- Cross-Specialty
- Medical Subspecialties
- Neurology
- Pain & Palliative
- Psychiatry
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.75 credits
- MOC · Up to 0.75 points
- Commercial Support
-
ReleasedJan 26, 2026
-
Last day to claim creditJan 27, 2027 4 months left
-
HMP Education Advancing Schizophrenia Care: Improving Outcomes with Muscarinic Modulators
-
HMP Education Challenging Cases in Schizophrenia: Practical Considerations of Muscarinic Therapies in Practice
-
Neuroscience Education Institute +1 Of Musc and Men: The Exciting Potential of Muscarinic Receptor Modulation in the Treatment of Schizophrenia
